Atrial Fibrillation Screening-to-Anticoagulation Pathways in Low- and Middle-Income Countries

BACKGROUND: Atrial fibrillation (AF) is an important cause of preventable stroke in low- and middle-income countries (LMICs), where diagnostic and treatment gaps may limit screening effectiveness. OBJECTIVES: This study aims to evaluate AF screening in LMICs as a screening-to-anticoagulation pathway, focusing on reach, equity, diagnostic confirmation, anticoagulation uptake, and health-system capacity. METHODS: MEDLINE via PubMed, Embase, CINAHL, Web of Science, and CENTRAL were searched from inception to July 2026. LMIC studies reporting population-facing AF screening or screening-linked care were included. Logit-transformed proportions were pooled using restricted maximum-likelihood random-effects models with modified Hartung-Knapp CIs; binomial-normal generalized linear mixed models were used in sensitivity analyses. Pathway stages were synthesized from outcome-specific study subsets rather than a single longitudinal cohort. RESULTS: = 99.2%; prediction interval: 0.08%-9.97%). In separate study subsets, prior AF awareness was 50.7%, study-defined high stroke risk or oral anticoagulation indication was 78.9%, and oral anticoagulation coverage among study-defined eligible/high-risk participants was 22.8%. Reach ranged from 9.7% to 98.8%, and confirmation completion was 57.5% to 61.8% in 2 programs. CONCLUSIONS: AF screening in LMICs identifies substantial but highly variable detection and treatment gaps. Pooled proportions should be interpreted as cross-study summaries rather than expected rates for a specific setting. Effective programs require representative reach, timely confirmation, appropriate stroke-risk and valvular assessment, access to anticoagulation, and longitudinal follow-up.

Authors

Institutions

Publication Details

Journal
JACC Advances
Published
2026-11-16
DOI
https://doi.org/10.1016/j.jacadv.2026.103479
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Atrial Fibrillation Screening-to-Anticoagulation Pathways in Low- and Middle-Income Countries

G. André Ng, Kaveh Hosseini, Mirvat A. Alasnag, Sadeer G Al-Kindi et al.
1 links
JACC Advances
Atrial Fibrillation Management and Outcomes
article

Atrial Fibrillation Screening-to-Anticoagulation Pathways in Low- and Middle-Income Countries

G. André Ng, Kaveh Hosseini, Mirvat A. Alasnag, Sadeer G Al-Kindi, Zainab Atiyah Dakhil, Marwan M. Refaat, W M Al Mahmeed, Mustafa Zakkar, Eyad Jamileh, Ibrahim Antoun, Fahad Muhammad, Omar Farooq, Jassim Al Suwaidi, Riyaz Somani
article en

Abstract

BACKGROUND: Atrial fibrillation (AF) is an important cause of preventable stroke in low- and middle-income countries (LMICs), where diagnostic and treatment gaps may limit screening effectiveness. OBJECTIVES: This study aims to evaluate AF screening in LMICs as a screening-to-anticoagulation pathway, focusing on reach, equity, diagnostic confirmation, anticoagulation uptake, and health-system capacity. METHODS: MEDLINE via PubMed, Embase, CINAHL, Web of Science, and CENTRAL were searched from inception to July 2026. LMIC studies reporting population-facing AF screening or screening-linked care were included. Logit-transformed proportions were pooled using restricted maximum-likelihood random-effects models with modified Hartung-Knapp CIs; binomial-normal generalized linear mixed models were used in sensitivity analyses. Pathway stages were synthesized from outcome-specific study subsets rather than a single longitudinal cohort. RESULTS: = 99.2%; prediction interval: 0.08%-9.97%). In separate study subsets, prior AF awareness was 50.7%, study-defined high stroke risk or oral anticoagulation indication was 78.9%, and oral anticoagulation coverage among study-defined eligible/high-risk participants was 22.8%. Reach ranged from 9.7% to 98.8%, and confirmation completion was 57.5% to 61.8% in 2 programs. CONCLUSIONS: AF screening in LMICs identifies substantial but highly variable detection and treatment gaps. Pooled proportions should be interpreted as cross-study summaries rather than expected rates for a specific setting. Effective programs require representative reach, timely confirmation, appropriate stroke-risk and valvular assessment, access to anticoagulation, and longitudinal follow-up.

JACC AdvancesVol. 5(12)
University of Copenhagen (DK), Houston Methodist (US), University of Baghdad (IQ), University of Leicester (GB), University Hospitals of Morecambe Bay NHS Foundation Trust (GB), University of Lancashire (GB), Glenfield Hospital (GB), University Hospitals of Leicester NHS Trust (GB), Copenhagen University Hospital (DK), Gentofte Hospital (DK), King Fahd Armed Forces Hospital (SA), Royal Blackburn Teaching Hospital (GB), Cleveland Clinic Abu Dhabi (AE), Hamad Medical Corporation (QA), East Lancashire Hospitals NHS Trust (GB), American University of Beirut (LB)
British Heart Foundation, Medical Research Council
Good health and well-being
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon